Details for Patent: 11,851,504
✉ Email this page to a colleague
Which drugs does patent 11,851,504 protect, and when does it expire?
Patent 11,851,504 protects MONOFERRIC and is included in one NDA.
This patent has forty-two patent family members in twenty-five countries.
Drugs Protected by US Patent 11,851,504
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacosmos | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | 11,851,504 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| Pharmacosmos | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | 11,851,504 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| Pharmacosmos | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-002 | Jan 16, 2020 | DISCN | Yes | No | 11,851,504 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,851,504
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2411053 | ⤷ Subscribe | C02411053/01 | Switzerland | ⤷ Subscribe |
| Australia | 2009342799 | ⤷ Subscribe | |||
| Brazil | PI0924653 | ⤷ Subscribe | |||
| Canada | 2756580 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
